SCHEMBL2656757

SCHEMBL2656757

CC(CC(=O)Nc1nccs1)Oc1cccc(C(=O)OC(C)(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.52
▸ RAB9A P51151 6/20 0.52
▸ SMN1; SMN2 Q16637 5/20 0.52
▸ HPGD P15428 2/20 0.52
▸ LMNA P02545 1/20 0.47
▸ TP53 P04637 2/20 0.47
▸ THRB P10828 1/20 0.47
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ ADORA2A P29274 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ GCK P35557 6/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ NFKB1 P19838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2656267 0.87 NPC1 (0.56) NPC1RAB9ASMN1; SMN2HPGDLMNA
SCHEMBL2656759 0.82 HPGD (0.54) NPC1RAB9ASMN1; SMN2HPGDLMNA
SCHEMBL2657624 0.80 NPC1 (0.53) NPC1RAB9ASMN1; SMN2HPGDLMNA
SCHEMBL2656141 0.77 ADORA2A (0.54) NPC1RAB9ASMN1; SMN2HPGDLMNA
SCHEMBL27652020 0.73 RAB9A (0.74) NPC1RAB9ASMN1; SMN2HPGDLMNA
SCHEMBL30625924 0.70 KMT2A (0.52) NPC1RAB9ASMN1; SMN2LMNAMEN1
Hydrochloric Acid SCHEMBL7381662 0.70 MEN1 (0.54) NPC1RAB9ASMN1; SMN2HPGDLMNA
SCHEMBL12238632 0.69 ADORA2A (0.71) NPC1RAB9ASMN1; SMN2HPGDLMNA
SCHEMBL30099022 0.68 RAB9A (0.77) NPC1RAB9ASMN1; SMN2HPGDTHRB
SCHEMBL2656269 0.68 HPGD (0.59) NPC1RAB9ASMN1; SMN2HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125735-A2 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION Advinus Therapeutics Private Limited (IN) 2009-12-02 — — EP disclosed
WO-2008104994-A2 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2008-09-04 — — WO disclosed
Send feedback